BioWorld - Thursday, February 12, 2026

BioWorld Science

March 8, 2022

View Archived Issues

BMAL1 disruption has an impact on metabolic and liver disease

Read More

Nanoengineered Bifidobacterium bifidum suppresses tumors in vivo

Read More

LABP-73 demonstrates efficacy in preclinical models of chronic asthma

Read More

METTL3 inhibition with STM-2457 leads to antitumor effects in OSCC

Read More

Study finds variants that increase risk of severe COVID-19

Read More

Novartis enters license option agreement with Voyager for AAV capsids for gene therapy programs

Read More

Kidney organoids as models of tubular injury reveal a key role of HDR genes in kidney repair

Read More

SiteOne Therapeutics patents Nav1.7 inhibitors for pain

Read More

Bristol Myers Squibb describes FPR2 and FPR1 agonists

Read More

CTLs and arachidonic acid from the tumor microenvironment induce tumor ferroptosis mediated by ACSL4

Read More

Local hyperthermia therapy activates beige fat through HSF1 and may be helpful against obesity

Read More

Akebia Therapeutics reports prolyl 4-hydroxylase inhibitors

Read More

Bridge signs option agreement for CellionBioMed's ion channel modulator for IPF

Read More

Dana-Farber Cancer Institute patents USP28 inhibitors for cancer

Read More

Sunshine Lake Pharma researchers describe JAK inhibitors

Read More

Ixaka's CELTIC-19 targeted nanoparticle product granted ATMP classification

Read More